Obesity and type 2 diabetes market closely linked but vastly different in outlook
11-Mar-2010
- Australia
Most read news
Topics
obesity
inhibitors
Datamonitor
Sanofi-aventis
regulatory approval
Merck
Januvia
Janumet
GlaxoSmithKline
dosing
Avandia
Abbott
Pioglitazone
metformin
Organizations
Datamonitor
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.